Evaluation of the glycolytic response of in vitro cell models to metabolic stress
ImmuTune IMP731 has demonstrated potency at low doses in preclinical models of T-cell mediated inflammation
A looked at the number of demyelinating features that are needed to differentiate between CIDP, Amyotrophic lateral sclerosis and diabetic neuropathy.